Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety

Completed · Phase 2 · Has a placebo group

Conditions studied: Performance Anxiety

In brief

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female participants with performance anxiety.

Key facts

Study ID
NCT04800237
Run by
Vanda Pharmaceuticals
People needed
230
Starts
2021-02-23
Expected to finish
2022-08-02
Last updated by the study team
2024-03-20

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.